News
Sanofi’s MenQuadfi Gets EU Approval for Infants Against Invasive Meningococcal Disease
MenQuadfi was previously approved in the European Union for individuals aged 12 months and older against invasive meningococcal disease.
E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
MenQuadfi was previously approved in the European Union for individuals aged 12 months and older against invasive meningococcal disease.
HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
